Attend this session to learn about recent research from the BIO Industry Analysis team on the history and future of vaccine pipelines. A dynamic conversation on how to finance this space along with the emergence of platform technologies, mRNA, and monoclonal antibodies will discuss how to continue the advancement through the clinic and to get vaccines to populations around the world.